TORONTO, ON – July 2, 2025 – HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), a leader in AI-driven preventative care, today confirmed the decisive voting outcomes from its Annual General Meeting of Shareholders held on June 30, 2025. A strong mandate from shareholders was evident, with approximately 71% of the Company’s outstanding shares represented either in person or by proxy.
The meeting saw overwhelming approval for all key resolutions outlined in the management information circular, including the crucial decisions to set the board size at six directors, re-elect all six incumbent directors, and formally appoint Deloitte LLP as the Company’s auditor. This broad shareholder backing signals confidence in HEALWELL AI’s strategic direction and governance.
Further details on the voting results are as follows:
Director Elections: A Clear Mandate
The proposal to fix the number of directors at six received robust support, garnering 383,458,757 votes, or a commanding 99.99% of votes cast. This overwhelming endorsement underscores shareholder confidence in the current leadership structure.
Detailed proxy voting results for the election of the six nominated directors demonstrate significant shareholder approval:
| Nominee | Votes For | % For | Votes Withheld | % Withheld |
| Alexander Dobranowski | 383,002,346 | 99.89 | 433,749 | 0.11 |
| Hamed Shahbazi | 381,169,847 | 99.41 | 2,226,248 | 0.59 |
| Erik Danudjaja | 381,150,107 | 99.40 | 2,285,988 | 0.60 |
| Ian McCrae | 382,984,998 | 99.88 | 451,097 | 0.12 |
| Sam Englebardt | 383,379,571 | 99.98 | 56,524 | 0.02 |
| Tina Raja | 383,374,202 | 99.98 | 61,894 | 0.02 |
Auditor Appointment: Strengthening Financial Oversight
In a move that further solidifies the company’s commitment to robust financial reporting, Deloitte LLP was appointed as the new external auditor, succeeding PricewaterhouseCoopers LLP. This critical decision garnered near-unanimous support, with 383,435,323 votes cast in favor, representing approximately 99.98% of the votes cast. This transition is a key step in maintaining the highest standards of corporate governance.
For a comprehensive overview of the meeting’s resolutions and detailed business discussions, shareholders are encouraged to review the Company’s Management Information Circular, accessible via SEDAR+ at www.sedarplus.ca.
About HEALWELL AI
HEALWELL AI is at the forefront of healthcare innovation, leveraging artificial intelligence to pioneer a new era of preventative care. The company’s core mission is to revolutionize healthcare by enabling the early identification and detection of diseases, ultimately aiming to save lives. Through its proprietary technology, HEALWELL AI is developing advanced clinical decision support systems designed to empower healthcare providers. These systems facilitate the diagnosis of rare and chronic conditions, enhance practice efficiency, and critically, lead to improved patient health outcomes. HEALWELL AI is actively pursuing a growth strategy built on the development and acquisition of cutting-edge technology and clinical expertise that aligns with its forward-looking roadmap. The company is publicly traded on the Toronto Stock Exchange under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF.” Discover more about HEALWELL AI at https://healwell.ai/ .
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/257510
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/3827.html
